Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies

被引:40
|
作者
Lin, Richard J. [1 ]
Elko, Theresa A. [1 ]
Devlin, Sean M. [2 ]
Shahrokni, Armin [3 ,4 ]
Jakubowski, Ann A. [1 ,4 ]
Dahi, Parastoo B. [1 ,4 ]
Perales, Miguel-Angel [1 ,4 ]
Tamari, Roni [1 ,4 ]
Shaffer, Brian C. [1 ,4 ]
Sauter, Craig S. [1 ,4 ]
Papadopoulos, Esperanza B. [1 ,4 ]
Gyurkocza, Boglarka [1 ,4 ]
Korc-Grodzicki, Beatriz [3 ,4 ]
Barker, Juliet N. [1 ,4 ]
Maloy, Molly A. [1 ]
Giralt, Sergio A. [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Adult BMT Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Geriatr Serv, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; COMORBIDITY INDEX; RISK-ASSESSMENT; SURVIVAL; AGE; VALIDATION; FERRITIN; ALBUMIN;
D O I
10.1038/s41409-019-0654-6
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Older patients are at increased risk for complications and death following allogeneic hematopoietic cell transplantation (allo-HCT). Traditional transplant-specific prognostic indices such as hematopoietic cell transplant comorbidity index (HCT-CI) may not capture all underlying geriatric vulnerabilities, and in-depth evaluation by a geriatrician prior to transplant may not always be available. We hypothesize that routine pretransplant interdisciplinary clinical assessment may uncover prognostically important geriatric deficits. Using an institutional database of 457 adults aged 60 years and older who underwent first allo-HCT for hematological malignancies from 2010 to 2017, we examined the prognostic impact of pretransplant deficits in geriatric domains of function, mobility, mood, medication, nutrition, and relevant biochemical markers. We found that impairment in instrumental activities of daily living (IADL) was associated with reduced survival through increased nonrelapse mortality (NRM, HR=1.82; 95% CI, 1.04-3.19). The combination of IADL impairment with either HCT-CI/age index or disease risk index readily stratified NRM and overall survival, respectively. In addition, we found that even mild renal dysfunction adversely impacted survival in older transplant patients. Our findings establish important geriatric vulnerabilities in older patients prior to allo-HCT and may provide an entry point for prospective, interventional trials to improve their outcomes.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [41] Coping in patients with hematologic malignancies undergoing hematopoietic cell transplantation
    Newcomb, Richard
    Amonoo, Hermioni L.
    Nelson, Ashley M.
    Choe, Joanna
    Holmbeck, Katherine
    Nabily, Anisa
    Lee, Stephanie J.
    Leblanc, Thomas W.
    El-Jawahri, Areej
    BLOOD ADVANCES, 2024, 8 (06) : 1369 - 1378
  • [42] Fungal Pneumonia in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation
    Pergam, Steven A.
    CLINICS IN CHEST MEDICINE, 2017, 38 (02) : 279 - 294
  • [43] Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies
    Green, Margaret L.
    CLINICS IN CHEST MEDICINE, 2017, 38 (02) : 295 - +
  • [44] FACTORS PREDICTIVE OF RELAPSE OF HEMATOLOGIC MALIGNANCIES IN PEDIATRIC PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (ALLOHCT)
    Shah, Nirali
    Borowitz, Michael
    Steinberg, Seth
    Robey, Nancy
    Gamper, Christopher
    Loeb, David
    Symons, Heather
    Wayne, Alan
    Chen, Allen
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S96 - S96
  • [45] Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
    Baron, F
    Baker, JE
    Storb, R
    Gooley, TA
    Sandmaier, BM
    Maris, MB
    Maloney, DG
    Heimfeld, S
    Oparin, D
    Zellmer, E
    Radich, JP
    Grumet, FC
    Blume, KG
    Chauncey, TR
    Little, MT
    BLOOD, 2004, 104 (08) : 2254 - 2262
  • [46] Acupuncture in hematologic malignancies and hematopoietic cell transplantation
    El Iskandarani, Sarah
    Deng, Gary
    BLOOD REVIEWS, 2022, 56
  • [47] TRANSPLANTATION OF ALLOGENEIC PBSC IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    MAJOLINO, I
    SCIME, R
    BUSCEMI, F
    INDOVINA, A
    VASTA, S
    SANTORO, A
    PAMPINELLA, M
    CATANIA, P
    CAVALLARO, AM
    FIANDACA, T
    FABBIANO, F
    MIRTO, S
    MARCENO, R
    CARONIA, F
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 755 - 755
  • [48] Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies
    Ramos, Carlos A.
    Saliba, Rima M.
    de Padua, Leandro
    Khorshid, Ola
    Shpall, Elizabeth J.
    Giralt, Sergio
    Patah, Poliana A.
    Hosing, Chitra M.
    Popat, Uday R.
    Rondon, Gabriela
    Khouri, Issa F.
    Nieto, Yago L.
    Champlin, Richard E.
    de Lima, Marcos
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 249 - 257
  • [49] Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies
    Olsson, R. F.
    Logan, B. R.
    Chaudhury, S.
    Zhu, X.
    Akpek, G.
    Bolwell, B. J.
    Bredeson, C. N.
    Dvorak, C. C.
    Gupta, V.
    Ho, V. T.
    Lazarus, H. M.
    Marks, D. I.
    Ringden, O. T. H.
    Pasquini, M. C.
    Schriber, J. R.
    Cooke, K. R.
    LEUKEMIA, 2015, 29 (08) : 1754 - 1762
  • [50] Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies
    R F Olsson
    B R Logan
    S Chaudhury
    X Zhu
    G Akpek
    B J Bolwell
    C N Bredeson
    C C Dvorak
    V Gupta
    V T Ho
    H M Lazarus
    D I Marks
    O T H Ringdén
    M C Pasquini
    J R Schriber
    K R Cooke
    Leukemia, 2015, 29 : 1754 - 1762